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Abstract: Marine invertebrates have proven to be a rich source of secondary metabolites. 
The growing recognition that marine microorganisms associated with invertebrate hosts are 
involved  in  the  biosynthesis  of  secondary  metabolites  offers  new  alternatives  for  the 
discovery  and  development  of  marine  natural  products.  However,  the  discovery  of 
microorganisms producing secondary metabolites previously attributed to an invertebrate 
host poses a significant challenge. This study describes an efficient chemical screening 
method utilizing a 96-well plate-based bacterial cultivation strategy to identify and isolate 
microbial producers of marine invertebrate-associated metabolites.  
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1. Introduction  
Marine invertebrates are a well recognized source of new bioactive natural products with substantial 
potential for development as human therapeutics [1–7]. Despite the great potential of many natural 
products derived from marine invertebrates, the realization of this potential is frequently hindered by 
the inability of the natural source to provide sufficient quantities of the bioactive component to support 
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traditional  drug  testing  and  development  activities  [8].  This  ―supply  issue‖  is  one  of  the  greatest 
challenges facing the development of marine natural products. 
There is a growing recognition that microorganisms associated with marine invertebrate hosts play 
an  important  role  in  the  biosynthesis  of  secondary  metabolites.  As  such,  this  could  offer  a  new 
alternative  to  the  production  of  potential  drug-leads  isolated  from  marine  invertebrates  [7,9,10]. 
Indeed, culturing invertebrate-associated microbes responsible for natural product biosynthesis would 
provide one approach to develop a sustainable supply of marine natural product leads [11]. However, 
the  discovery  of  microorganisms  producing  secondary  metabolites  previously  attributed  to  an 
invertebrate host has thus far, met with only modest success [12–14]. The isolation and cultivation of 
microbial  symbionts  remains  as  a  significant  challenge  due  to  their  potential  dependence  on  host 
supplied factors for growth and secondary metabolite production [7,10].  
This report describes a novel chemically oriented screen based on ultra high performance liquid 
chromatography/mass  spectrometry  (UPLC/MS)  to  direct  the  isolation  of  invertebrate-associated 
microorganisms implicated in the biosynthesis of secondary metabolites previously identified from the 
host invertebrate. This contrasts with the more conventional approach of prioritizing microbial isolates 
based on phylogenetic analysis and bioassay data. While this traditional approach is clearly of value, 
this  provides  only  limited  information  on  the  ability  of  the  isolates  to  produce  novel  secondary 
metabolites. A traditional chemical analysis of microbial culture extracts is of obvious value; however, 
this typically is a slow, tedious process. Herein, we describe a high-throughput chemically guided 
microbial  isolation  strategy  which  is  facilitated  by  performing  mixed  bacterial  cultures  in  a  96  
multi-well  plate  (MWP)  format  and  the  use  of  new  UPLC/MS  technology  as  a  rapid  chemical 
screening tool. The high-throughput nature of the MWPs greatly facilitated the parallel investigation of 
multiple growth conditions while also greatly accelerating the chemical screening of MWP cultures 
[15].  The  MWPs  are  employed  for  three  separate  culturing  steps:  (1)  growth  of  mixed  bacterial 
cultures derived from coral homogenate inocula in multiple media conditions, (2) growth of axenic 
cultures  purified  from  mixed  bacterial  assemblages,  and  (3)  optimization  of  media  conditions  to 
maximize yields of target compounds produced by bacteria purified from mixed cultures. 
A chemical screening strategy can benefit from the use of standards (or target-molecules) which can 
be  rapidly  characterized  by  diagnostic  parameters.  Our  approach  utilizing  UPLC/MS  thus  used 
retention time and MS data. Thus, the initial step of the study was a UPLC/MS investigation of the 
gorgonian  coral  Erythropodium  caribaeorum  (EC)  in  order  to  create  an  UPLC/MS  library  of  
target-molecules. EC was selected as a representative coral as it is abundant in many regions of the 
Caribbean and is known to possess a rich diversity of secondary metabolites [16–20]. MWP cultures of 
mixed  microbial  populations  derived  from  coral  homogenate  inocula  were  performed  in  multiple 
growth  conditions.  Factors  controlling  secondary  metabolite  production  in  complex  marine 
microorganism-invertebrate assemblages are largely unknown and thus we endeavored to expose the 
inoculated  bacteria  to  a  vast  array  of  culture  conditions  which  would  hopefully  allow  for  the 
establishment of an equally diverse number of cultures, thus increasing our chances of identifying a 
culture producing an EC metabolite. A 96 MWP format was utilized for the growth of axenic cultures 
purified  from  selected  mixed  microbial  assemblages  to  identify  the  microbial  producers  of  three 
secondary  metabolites  previously  found  in  the  gorgonian  EC  and  secondly,  to  maximize  
production yield. Mar. Drugs 2011, 9                      
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2. Results and Discussion  
2.1. UPLC/MS Library of EC Secondary Metabolites 
A  UPLC/MS  library  of  metabolites  from  EC  was  established  to  provide  ―standards‖  for  the 
chemical screening of mixed bacterial cultures derived from EC tissue homogenates. Each member of 
the library was characterized by retention time, full MS and tandem MS/MS data of the most abundant 
ion using a standardized method. While the goal was not to identify each component of this mixture, 
amongst the 82 metabolites characterized in this manner, a few components could be readily identified 
by comparison with published data. The most abundant secondary metabolites present in EC extracts, 
erythrolides A and B (RT 2.05 min, 419.2 amu and RT 2.16 min, 479.1 amu, respectively) [16], were 
readily detected as were the potent antimitotic compounds, eleutherobin and desmethyleuleutherobin 
(RT 2.04 min, 657.2 amu, RT 1.69 min, 643.3 amu, respectively) [19]. 
2.2. Screening Mixed Cultures for “EC Metabolites” 
The chemical diversity of EC is evident by the large number of metabolites readily detected by 
UPLC/MS. A mixed culture strategy employing a small scale 96 MWP growth format was used to 
query  the  relationship  between  the  chemical  diversity  observed  in  EC  extracts  and  the  microbial 
community  associated  with  this  gorgonian.  Employing  this  format,  a  homogenized  EC  tissue 
preparation  was  used  to  inoculate  1536  different  culture  conditions  in  order  to  expose  the  mixed 
microbial community to a variety of selective pressures and an array of nutritional resources with 
which to support secondary metabolite biosynthesis. We subsequently applied the UPLC/MS chemical 
screen previously used to create the EC metabolite library to analyze each of the 1536 mixed cultures 
for  the  production  of  the  82  metabolites  initially  observed  in  the  coral  extract.  Direct  chemical 
screening of such large numbers of samples has only recently been made feasible with the advent of 
UPLC technology which allows for the analysis of a large number of samples in a short period of time 
while increasing sensitivity and resolution [21–23]. For example, one 96 MWP plate can be analyzed 
by UPLC/MS and the data processed (using a customized application from the software Xcalibur
TM), 
allowing for the quantification of the 82 metabolites in each well in approximately 10 hours. 
Four enrichment plates with 96 different conditions as described in Table 1 were prepared, and 
inoculated with  EC homogenate and  incubated at 30 ° C and 37 °C  under both static  and  shaken  
(150 rpm) conditions. The MWPs contained a nutritionally diverse array of media which varied in 
carbon source, nitrogen source and pH. The antibiotics penicillin G and kanamycin were added to 
select for the establishment of mixed cultures dominated by different groups of bacteria which exhibit 
natural resistance to these antibiotics. The goal of the enrichment plates was to generate a continuum 
of microbial diversity that could be further fermented and ultimately screened for the production of  
EC metabolites. 
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Table 1. Enrichment plate layout. 
  No Antibiotics  +Penicillin G  +Kanamycin 
  1  2  3  4  5  6  7  8  9  10  11  12 
A  NB 
NB 
pH 5.8 
1/10 NB 
pH 5.8 
MB 
pH 5.8 
NB 
NB 
pH 5.8 
1/10 NB 
pH 5.8 
MB 
pH 5.8 
NB 
NB 
pH 5.8 
1/10 NB 
pH 5.8 
MB 
pH 5.8 
B  LB 
NB 
pH6.5 
1/10 NB 
pH6.5 
MB 
pH6.5 
LB 
NB 
pH6.5 
1/10 NB 
pH6.5 
MB 
pH6.5 
LB 
NB 
pH6.5 
1/10 NB 
pH6.5 
MB 
pH6.5 
C  MB 
NB 
pH 7.2 
1/10 NB 
pH 7.2 
MB 
pH 7.2 
MB 
NB 
pH 7.2 
1/10 NB 
pH 7.2 
MB 
pH 7.2 
MB 
NB 
pH 7.2 
1/10 NB 
pH 7.2 
MB 
pH 7.2 
D  TB 
NB 
pH 8.0 
1/10 NB 
pH 8.0 
MB 
pH 8.0 
TB 
NB 
pH 8.0 
1/10 NB 
pH 8.0 
MB 
pH 8.0 
TB 
NB 
pH 8.0 
1/10 NB 
pH 8.0 
MB 
pH 8.0 
E  dH20 
ISP1 
10µ g/mL 
NA 
NB + 
0.5% 
butanol 
1/10 MB 
pH 5.8 
dH20 
ISP1 
10µ g/mL 
NA 
NB + 
0.5% 
butanol 
1/10 MB 
pH 5.8 
dH20 
ISP1 
10µ g/mL 
NA 
NB + 
0.5% 
butanol 
1/10 MB 
pH 5.8 
F 
M9 
glycerol 
NB/SW  ASW 
1/10 MB 
pH6.5 
M9 
glycerol 
NB/SW  ASW 
1/10 MB 
pH6.5 
M9 
glycerol 
NB/SW  ASW 
1/10 MB 
pH6.5 
G 
M9 
glucose 
Emerson 
ASW 
glycerol 
1/10 MB 
pH 7.2 
M9 
glucose 
Emerson 
ASW 
glycerol 
1/10 MB 
pH 7.2 
M9 
glucose 
Emerson 
ASW 
glycerol 
1/10 MB 
pH 7.2 
H 
M9 
arabinose 
R2 Broth 
ASW 
glucose 
1/10 MB 
pH 8.0 
M9 
arabinose 
R2 Broth 
ASW 
glucose 
1/10 MB 
pH 8.0 
M9 
arabinose 
R2 Broth 
ASW 
glucose 
1/10 MB 
pH 8.0 
Figure 1. Comparison of the MS/MS spectra of extracts derived from the mixed bacterial 
culture and the coral Erythropodium caribaeorum. 
 
After 7 days, the 4 enrichment plates representing 384 different cultures were subcultured into four 
96-MWPs containing either the same array of media as the enrichment plates, or uniformly filled with 
Terrific Broth (TB), Marine Broth (MB) or 1/10 MB medium. Subcultured plates were incubated for 
an additional 14 days at 30 ° C under static conditions to allow for the accumulation of secondary Mar. Drugs 2011, 9                      
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metabolites in the mixed cultures. Glycerol stocks were prepared from the four enrichment plates and 
the remaining culture broths (1.4 mL) were extracted and analyzed by UPLC/MS employing the same 
method used to generate the EC metabolite library. After 14 days of incubation, glycerol stocks from 
the  16  subcultured  MWPs  were  prepared  and  the  remaining  culture  broths  were  analyzed  by 
UPLC/MS,  and  compared  to  the  EC  metabolite  library.  Among  the  82  metabolites,  three  target 
molecules, compounds 41 (RT 2.48 min, 534.4 amu), 47 (RT 2.59 min, 620.3 amu) and, 53 (2.75 min, 
706.3 amu) were detected in two mixed cultures across the 16 MWPs analyzed. The matches between 
the EC metabolite library and the bacterial mixed culture experiments were confirmed by comparison 
of their MS/MS spectra (Figure 1). Moreover, the MS data of compounds 41, 47, and 53 indicated that 
these  three  compounds  belonged  to  a  family  of  metabolites  which  possess  varying  amounts  of 
repeating units with a mass of 86 amu. 
2.3. Isolation and Identification of Pure Cultures Producing Target Compounds 41, 47 and 53 
While it was interesting to confirm production of natural products 41, 47 and 53 in mixed cultures, 
our goal was to use the described strategy to obtain pure cultures capable of producing compounds 
identified in the 82-member coral metabolite library. Thus, the MWP chemical screening strategy was 
used to guide the isolation of the microbial producer by testing growth cultures of single isolates. To 
obtain pure isolates of the bacterial producers of target compounds 41, 47 and 53, glycerol stocks made 
from Subculture Plate 1 derived from Enrichment Plate 1 (plate 1-1) well D5 (TB medium + penicillin 
G) and Subculture Plate 1 derived from Enrichment Plate 2 (plate 2-1) well B1 (LB medium) were 
plated on TB agar and LB agar, respectively. Thirty six colonies were picked according their physical 
appearance and morphology and inoculated in 1.7 mL of NB, LB, TB, M9 glycerol and ASW glycerol 
media  dispensed  in  a  MWP.  After  14  days  at  30  °C ,  the  plates  were  extracted  and  analyzed  by 
UPLC/MS. Three colonies isolated from plate 1-1 well D5 (E1-1D5g, E1-1D5i, and E1-1D5j) and two 
colonies isolated from plate 2-1 well B1 (E2-1B1a and E2-1B1d) revealed the presence of the target 
compounds. Isolates E1-1D5j and E1-1D5g exhibited strong production in TB medium. The targeted 
compounds were also detected in the relatively nutritionally lean medium ASW glycerol for colonies 
E1-1D5i  and  E2-1B1a.  The  production  of  the  target  metabolites  by  these  cultures  was  further 
confirmed by tandem mass spectrometry. 
2.4. Structure Elucidation of Compounds 41, 47 and 53 
The isolation and the identification of secondary metabolites from microorganisms often requires 
large culture volumes and multiple chromatographic steps in order to purify small amount of material 
from a complex mixture of microbial metabolites and media components. Our approach allowed us to 
rapidly identify and purify targeted compounds (41, 47, and 53) from the EC extract using standard 
chromatographic techniques. Compound 47 was characterized by 1D and 2D NMR analysis as well as 
tandem mass spectroscopy and identified as an oligomer containing seven 3-hydroxybutyric acid units. 
Due to observed differences of 86 amu in the mass spectra, compounds 41 and 53 were determined to 
possess six and eight 3-hydroxybutyric acid units, respectively. 
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2.5. Media Optimization  
To further validate the utility of the MWP cultivation format and to identify improved conditions 
for the production of 41, 47 and 53 by EC isolates E1-1D5g, E1-1D5i, and E1-1D5j, a media study 
aimed at increasing metabolite yields was conducted. A full factorial approach to optimizing the TB 
media formulation was employed. Briefly, three arbitrary levels (low, medium and high) of the three 
primary  nutritional  media  components  (tryptone,  yeast  extract  and  glycerol)  of  TB  medium  were 
combined in all possible combinations, resulting in 27 media formulations which were dispensed in 
MWPs (Figure 2). Each of the 3 EC isolates were cultured in duplicate and the inoculated MWPs were 
incubated stationary for 14 days at 30 °C . Cultures were extracted and analyzed by UPLC/MS using 
methodology identical to that used to screen initial mixed cultures. The results of the media study are 
summarized in Figure 2. Several alternative TB medium formulations were identified which supported 
titers of 41, 47 and 53 1.3 to 5.23 fold greater than those supported by the standard TB medium 
formulation (TB14). Examination of Figure 2 indicates that yeast extract and tryptone concentrations 
had the most profound effect on formation of 41, 47 and 53. Increasing concentrations of yeast extract 
clearly inhibited their formation as titers consistently decreased in response to increasing yeast extract 
levels. Conversely, titers exhibited an increasing trend in  response to increasing concentrations of 
tryptone. In general mid-level glycerol concentrations appeared to support greater production levels 
than the high or low concentrations, however, the effect of glycerol on the yield of 41, 47 and 53 was 
less pronounced than the effects of tryptone and yeast extract. 
Figure 2. Results of Terrific Broth (TB) media optimization study. 
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2.6. Taxonomic Identification of Bacteria Producing 3-Hydroxybutyric Acid Oligomers 
To  determine  the  taxonomic  classification  of  the  EC-derived  colonies  E1-1D5-g,  -i,  -j  and  
E2-1B1-d, -a , the nearly complete 16S small subunit ribosomal RNA genes were amplified from 3 
replicate  colonies  of  each  of  the  5  isolates  by  PCR  and  the  resulting  amplicons  were  completely 
sequenced. Comparison of the 16S rDNA amplicons from the E1-1D5 isolates revealed that they were 
100%  identical,  indicating  that  the  three  isolates  were  identical  clones  purified  from  well  D5  of 
subculture plate 1-1. Comparison of the nearly full length 16S rRNA gene (1480 bp) to sequences 
contained within the GenBank non-redundant nucleotide database using the BlastN program indicated 
that the EC isolates shared 1479 out of 1480 residues with a number of Photobacterium damselae 
strains [24]. Comparison of the 16S rDNA amplicons from the E2-1B1-a and E2-1B1-d isolates also 
revealed that they were 100% identical, indicating that these isolates are identical clones purified from 
well B1 of subculture plate 2-1. Comparison of the nearly full length 16S rRNA gene (1547 bp) to 
sequences contained within the GenBank non-redundant nucleotide database using the BlastN program 
indicated that the 16S rDNA gene of EC isolates shared more than 98.5% identity with a number of 
Vibrio  harveyi  strains. The partial 16S  rRNA gene  sequences  for P.  damselae strain  E1-1D5  and 
V. harveyi strain E2-1B1 have been deposited in GenBank under accession numbers HM143776 and 
HM143777, respectively. 
3. Conclusions  
A rapid MWP-based mixed culture strategy was successfully employed to screen more than 1500 
small-scale mixed cultures for microbial producers of metabolites detected in organic extracts of the 
gorgonian coral EC. Small-scale MWP-based culturing paired with rapid UPLC/MS analysis affords 
an efficient method to not only identify natural products produced in mixed culture but also to evaluate 
axenic cultures. Inoculation of 1536 wells with EC tissue homogenate and subsequent rapid chemical 
screening by UPLC/MS resulted in the detection of 2 wells containing elevated quantities of three 
related  metabolites  identified  in  the  EC  extract.  The  three  metabolites  were  revealed  to  be  
3-hydroxybutyric acid oligomers containing 6 to 8 monomers by interpretation of NMR and LC/MS 
data. These compounds have not previously been reported from EC. Two axenic strains of bacteria 
were isolated from glycerol stocks prepared from the two wells originally exhibiting production, and 
were subsequently shown to be strains of P. damselae and V. harveyi via 16S rRNA gene sequencing. 
Both  Photobacterium  and  Vibrio are known to produce polyhydoxybutyrate  (PHB)  oligomers  and 
polymers and other polyhydroxyalkanoates [25–27]. In bacteria, PHB is commonly encountered as a 
high  molecular  weight  polymer  (150–30,000  monomer  units)  and  is  usually  accumulated  in 
intracellular light refractive granules when an essential nutrient such as nitrogen or phosphorous is 
limited in the presence  of excess carbon source, and is believed to function as an energy reserve 
[28,29]. Photobacterium and Vibrio are both ubiquitous marine bacteria belonging to the Vibronacea 
which are often associated with disease states in a number of marine organisms. The role of these 
bacteria in EC is not clear at this time; however, these microbes were isolated from tissue exhibiting no 
outward sign of disease.  Mar. Drugs 2011, 9                      
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The approach described above to identifying microbial producers of metabolites present in marine 
invertebrates represents a unique and rapid method which should be applicable to a variety of systems. 
Traditional strategies have relied on the isolation of axenic cultures from the invertebrate followed by 
growth under multiple culture conditions in hopes of identifying a microbial producer of the targeted 
metabolite. The latter approach suffers from a number of drawbacks. Firstly, significant resources are 
expended isolating, culturing and analyzing microbes which do not possess the capability to produce 
the compounds of interest. Secondly, culturing of axenic isolates may not provide the biochemical 
signals normally present in a complex microbial community necessary for the induction of secondary 
metabolite biosynthesis. Bacteria are well known to employ a number of biochemical signals to control 
gene expression, and natural product biosynthesis under laboratory conditions has been shown to rely 
on  signaling  between  different  species  of  a  marine  bacterial  population  [30,31].  Screening  mixed 
cultures for metabolite production avoids these potential pitfalls while simultaneously allowing for the 
subsequent  purification  of  axenic  cultures  from  archived  frozen  glycerol  stocks.  The  described 
methodology was also validated as a rapid and cost-effective tool for the preliminary optimization of 
growth conditions prior to more costly large scale cultures.  
4. Experimental Section  
4.1. Identification of Secondary Metabolites Present in EC 
Samples of EC (5 kg) were collected off the coast of Florida at a depth of 10 m in June 2007 and 
were extracted several times with a mixture ACN:DCM (1:1). The crude extract was fractionated by 
flash chromatography on C18 and the resulting fractions were further purified by normal phase Diol 
with a step gradient hexane-EtOAc-MeOH and reversed phase C18 column chromatography with a 
H2O-MeOH-DCM  stepwise  gradient  system.  All  the  fractions  were  analyzed  by  UPLC  (Thermo 
Scientific,  Accela)  coupled  to  an  ELSD  (Sedere,  Sedex  LT-ELSD  Model  80LT)  and  mass 
spectrometer (Thermo Scientific, LTQ ion trap) with a standard gradient from 5% ACN in H2O (0.1% 
formic acid in both eluents) to 100% ACN in 6 minutes. 
4.2. Chemical Screening of MWP Mixed Cultures 
E. caribaeorum was collected at Boca Raton, Florida in February 2007 by SCUBA at a depth of  
13 m. Coral specimens were individually flash frozen with liquid nitrogen and subsequently stored at 
−80  °C .  Flash-frozen  coral  (1  g) was  homogenized in 50  mL  artificial  sea water  (ASW) using  a 
commercial Waring blender. The contents were filtered through four layers of sterile cheesecloth and 
17.5 µL of coral homogenate was used to inoculate each well of 4 enrichment plates (96 MWPs) 
containing 1.7 mL of culture broth per well. The enrichment plates were composed of gradients of pH, 
salt, nitrogen source, carbon source and antibiotics (penicillin G or kanamycin) as illustrated in the 
Table 1. All media were prepared with deionized water and autoclaved to sterilize the medium unless 
otherwise noted. Media compositions were as follows: Emerson medium—yeast extract (10.0 g/L), 
beef extract (44 g/L), peptone (4 g/L), NaCl (25 g/L), glucose (10 g/L, added post sterilization) [32]; 
Artificial Sea Water (ASW) medium—Instant Ocean™ (36 g/L) and glucose or glycerol (4 g/L, added 
post sterilization); R2 medium—yeast extract (0.5 g/L), proteose peptone (0.5 g/L), casamino acids Mar. Drugs 2011, 9                      
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(0.5 g/L), soluble starch (0.5 g/L), sodium pyruvate (0.3 g/L), K2HPO4 (0.3 g/L), MgSO4 (0.05 g/L), 
glucose (0.5 g/L, added post sterilization), pH 7.2 [33]; ISP1 medium—pancreatic digest of casein  
(5 g/L), yeast extract (3 g/L), nalidixic acid (10 µg/mL post sterilization) [34]; M9 media—Difco™M9 
Minimal  Salts  5X  powder  (11.28  g/L)  and  glycerol  or  glucose  or  arabinose  (4  g/L,  added  post 
sterilization) [35]; MB—Difco™ Marine Broth 2216 (37.4 g/L) [36]; 1/10MB—Difco™ Marine Broth 
2216 (3.74  g/L), NaCl (18 g/L); NB—EMD Nutrient Broth powder (8 g/L) [37]; 1/10NB—EMD 
Nutrient Broth powder (0.8 g/L); NB/SW—EMD Nutrient Broth powder (8 g/L), Instant Ocean™  
(36 g/L); NB 0.5% butanol—EMD Nutrient Broth powder (8 g/L), butanol (5 mL/L); LB—EMD LB 
Broth Miller powder (25 g/L); TB—EMD TB powder (47.6 g/L) [35]. Buffered NB, 1/10 NB, MB and 
1/10 MB were generated by preparing the media as described above with the addition of the following 
0.1  M  Na2HPO47H2O  and  0.1  M  NaH2PO4H2O  per  litre  of  media;  pH  5.8,  7.9  mL  0.1  M 
Na2HPO47H2O and 92.1 mL 0.1 M NaH2PO4H2O; pH 6.5, 30.3 mL 0.1 M Na2HPO47H2O and  
69.7  mL  0.1  M  NaH2PO4H2O;  pH  7.2,  68.4  mL  0.1  M  Na2HPO47H2O  and  3.16  mL  0.1  M 
NaH2PO4H2O; pH 8.0, 93.2 mL 0.1 M Na2HPO47H2O and 6.8 mL 0.1 M NaH2PO4H2O. Penicillin 
G and kanamycin were added to wells as at a concentration of 10 µg/mL and 50 µg/mL, respectively. 
Following  inoculation,  the  four  enrichment  plates  were  covered  with  a  sterile  breathable  nylon 
adhesive membrane and incubated for 7 days under the following conditions: Enrichment Plate 1,  
30 °C /150 rpm; Enrichment Plate 2, 37 °C /150 rpm; Enrichment Plate 3, 30 °C /static; Enrichment 
Plate 4, 37 °C /static. Each enrichment plate was then subcultured using a 96-pin replicator (Boekel 
Scientific, USA) in four different 96 MWPs (Table 1). The first plate possessed the same layout as the 
enrichment  plate  (subculture  plate  1)  and  the  three  other  plates  were  uniformly  filled  with  TB 
(Subculture Plate 2), MB (Subculture Plate 3) or 1/10MB (Subculture Plate 4). The sixteen resulting 
subculture  plates  were  incubated  static  at  30  °C   for  14  days.  Prior  to  harvesting,  each  plate  was 
archived by transferring 100 µL from each well to shallow 96 MWPs and mixed with 100 µL 50% 
glycerol (w/v) and stored at −80 °C . The plates were centrifuged at 3000 ×  g at 24 °C  for 20 min, and  
1 mL of supernatant was transferred to a new 96 MWP and dried under vacuum using a Genevac EZ-2 
instrument (Genevac Inc, USA). Sterile deionized H2O (100 µL) was added to the dried residues and 
incubated for 10 min at room temperature with occasional shaking. ACN (900 µL) was added to the 
rehydrated residues and mixed thoroughly by repeated aspiration through a 1 mL pipette tip. The 
resulting extract was centrifuged at 1000 ×  g for 5 min. The supernatant was transferred to a new plate, 
dried under vacuum and dissolved in 100 µL of MeOH. Extracts were analyzed by UPLC/MS using 
the same method used to generate the EC target-molecule library. 
4.3. Chemical Screening of Axenic MWP Cultures 
A  portion  (5–10  µL)  of  mixed  culture  glycerol  stock  of  cultures  which  showed  production  of 
metabolites identified in EC extracts were diluted 50 fold in TB and LB liquid media and plated on TB 
agar  (media  prepared  as  for  liquid  media  described  above  but  amended  with  15  g/L  agar)  and 
incubated at 30 ° C for 7 days. Two representative colonies of each morphological type were used to 
inoculate the wells of a new MWP containing 1.7 mL of the following media: NB, LB, TB, M9 
glycerol and ASW glycerol. Plates were incubated static at 30 ° C for 14 days. Plates were extracted 
and analyzed in an identical fashion to that used for the original mixed culture plates. Mar. Drugs 2011, 9                      
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4.4. TB Media Optimization Study 
The standard TB medium formulation consists of tryptone (12 g/L), yeast extract (24 g/L), glycerol 
(4  g/L),  K2HPO4  (9.4  g/L)  and  KH2PO4  (2.2  g/L).  All  media  formulations  contained  identical 
concentrations of K2HPO4 and KH2PO4 while the levels of tryptone, yeast extract and glycerol were 
varied between low, mid and high levels (trypone: low 3 g/L, mid 12 g/L, high 18 g/L; yeast extract: 
low 6 g/L, mid 24 g/L, high 36 g/L; glycerol: low 1 g/L, mid 4 g/L, high 8 g/L). All media were 
autoclaved at 121 ° C for 15 min and 1.5 mL was dispensed in the wells of sterile MWPs. To prepare 
inocula for MWP cultures, three individual isolates (E1-1D5-g,-i,and –j) were used to inoculate 10 mL 
of TB (standard formulation) medium and cultured for 16 hr at 30 ° C and 150 rpm. A portion (5 µL) of 
these cultures were used to inoculate each well of the MWP. Duplicate MWP cultures were incubated 
at 30 ° C under static conditions for 14 days and were extracted and analyzed as described above for 
mixed microbial cultures. 
4.5. Structure Determination 
EC  crude  extract  (100g)  was  partitioned  between  MeOH  and  hexane.  After  evaporation  under 
vacuum, the MeOH extract (42 g) was consecutively fractionated by flash chromatography on C18 
(Phenomenex, Sepra C18-T (50 µm, 135 Å)) with a step gradient H2O:MeOH (9:1), H2O:MeOH (5:5), 
H2O:MeOH (2:8), ACN, acetone and DCM:MeOH (1:1) and flash chromatography on Diol with a step 
gradient of hexane to EtOAc to MeOH. The fraction (188 mg) containing the target compounds were 
further fractionated using an automated C18 chromatography system (Teledyne, Combiflash Rf) and 
compound 47 was finally purified by reversed phase HPLC (Phenomenex luna C18 5u, 250 ×  10 mm) 
using  an  isocratic  gradient  H2O  [0.1%  FA]:ACN  [0.1%  FA]  (30:70)  to  yield  to  a  white  powder  
(2.9 mg). Compound 47 was characterized by 1D and 2D NMR analysis (Bruker Avance 600 MHz) as 
well as tandem mass spectroscopy and identified as an oligomer containing seven 3-hydroxybutyric 
acid units. 
1H NMR (300 MHz, CDCl3) δ 5.30 (1H, m), 2.63 (1H, dd, J = 7.7, 15.5 Hz), 2.48 (1H, dd,  
J = 5.4, 15.5 Hz), 1.29 (3H, d, J = 6.4 Hz); 
13C NMR (75 MHz, CDCl3) δ 169.4 (s), 67.8 (d), 40.9 (d), 
19.9 (q). Due to observed differences of 86 amu in the mass spectra, compounds 41 and 53 were 
determined to possess six and eight 3-hydroxybutyric acid units, respectively. 
4.6. 16S rDNA Sequencing 
16S ribosomal RNA gene fragments were amplified using the GoTaq Green Master Mix PCR kit 
(Promega) according to the manufacturer’s specifications. Reactions (50 µL) contained 0.5 µM of each 
of the universal bacterial 16S rRNA primers E8F (5'-AGAGTTGATCCTGGCTCAG) and E1541R  
(5'-AAGGAGGTGATCCANCCRCA)  [38].  Template  DNA  was  prepared  by  dispersing  actively 
growing single colonies picked from TB agar plates in 50 µL of PCR grade DMSO. A portion of the 
DMSO  cell  suspension  (1.25  µL)  was  added  to  each  PCR  reaction  resulting  in  a  final  DMSO 
concentration of 5%. Thermal cycling parameters consisted of an initial denaturing step of 3 min at  
94 ° C and 30 cycles consisting of 1 min at 94 °C , 1 min at 54 ° C and 2 min at 72 ° C and a final 
extension  step  at  72  ° C  for  10  min.  PCR  products  were  purified  using  the  DNA  Clean  and 
Concentrator-5 kit (Zymo Research Corporation). Purity and concentration of purified PCR products Mar. Drugs 2011, 9                      
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were  assessed  by  agarose  gel  electrophoresis.  PCR  products  were  sequenced  by  The  Centre  for 
Applied Genomics (Toronto, CA). 
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